# Janus II Feasibility

> **NCT06556693** · NA · RECRUITING · sponsor: **Zoll Medical Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Sleep Apnea

## Interventions

- **DEVICE:** Dual Channel Stimulation

## Key facts

- **NCT ID:** NCT06556693
- **Lead sponsor:** Zoll Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-12
- **Primary completion:** 2028-04
- **Final completion:** 2034-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556693, "Janus II Feasibility". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06556693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*